AI drug discovery market to grow 30% CAGR, to reach US$ 35 bn by 2034; Novo, Lilly, BMS forge deals

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Falecalcitriol

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

36 API Suppliers, 12 USDMF, 7 CEP/COS, 3 JDMF, 1 EU WC, 5 KDMF, 7 NDC API, 24 Listed Suppliers, $ API Reference Price

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

118 FDF Dossiers, 35 FDA Orange Book, 40 Europe, 8 Canada, 16 Australia, 1 South Africa, 18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 0.25MCG, CAPSULE;ORAL - 0.5MCG, INJECTABLE;INJECTION - 0.001MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 0.002MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 17 SPI Pharma, 8 DKSH, 2 Faran Shimi Pharmaceutical, 3 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 5 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 BASF, 1 Finar, 3 Gangwal Chemicals, 3 Ingredion Pharma Solutions, 4 Kerry, 3 Lonza Capsugel, 2 Microlex e.U, 3 Pluviaendo, 1 Qualicaps, 19 Roquette, 4 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

36 Fillers, Diluents & Binders, 17 Taste Masking, 16 Parenteral, 15 Chewable & Orodispersible Aids, 14 Direct Compression, 12 Film Formers & Plasticizers, 10 Disintegrants & Superdisintegrants, 10 Coating Systems & Additives, 9 Solubilizers, 9 Topical, 8 Thickeners and Stabilizers, 8 Empty Capsules, 8 Co-Processed Excipients, 4 Granulation, 3 Coloring Agents, 2 Surfactant & Foaming Agents, 2 Controlled & Modified Release, 2 Emulsifying Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 5 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 46 Regulatory FDF Prices, 7 Annual Reports

MARKET PLACE

9 APIs, 12 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 2 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
24/02/2025	TAPI Technology & API Services	Israel	TEVA PHARMACEUTICAL INDUSTRIES LTD	12417	CALCITRIOL USP	1997-03-14	Active	II	N/A
24/02/2025	Catalent Pharma Solutions	U.S.A	CATALENT PHARMA SOLUTIONS LLC	15318	ROCALTROL (0.25MCG & 0.5MCG) SOFTGEL CAPSULE	2001-02-28	Inactive	II	N/A

Falecalcitriol

Falecalcitriol

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

36 API Suppliers

12 USDMF

7 CEP/COS

3 JDMF

1 EU WC

5 KDMF

7 NDC API

24 Listed Suppliers

$ API Reference Price

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

118 FDF Dossiers

35 FDA Orange Book

40 Europe

8 Canada

16 Australia

1 South Africa

18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 0.25MCG

CAPSULE;ORAL - 0.5MCG

INJECTABLE;INJECTION - 0.001MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 0.002MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

2 Rochem International Inc

17 SPI Pharma

8 DKSH

2 Faran Shimi Pharmaceutical

3 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 Pfanstiehl

4 ACG Worldwide

5 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 BASF

1 Finar

3 Gangwal Chemicals

3 Ingredion Pharma Solutions

4 Kerry

3 Lonza Capsugel

2 Microlex e.U

3 Pluviaendo

1 Qualicaps

19 Roquette

4 Seppic

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

36 Fillers, Diluents & Binders

17 Taste Masking

16 Parenteral

15 Chewable & Orodispersible Aids

14 Direct Compression

12 Film Formers & Plasticizers

10 Disintegrants & Superdisintegrants

10 Coating Systems & Additives

9 Solubilizers

9 Topical

8 Thickeners and Stabilizers

8 Empty Capsules

8 Co-Processed Excipients

4 Granulation

3 Coloring Agents

2 Surfactant & Foaming Agents

2 Controlled & Modified Release

2 Emulsifying Agents

1 Soft Gelatin

DIGITAL CONTENT

INJECTABLE;INJECTION - 0.001MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 0.002MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons